Find Copper Sulfate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

301 RELATED EXCIPIENT COMPANIES

512EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Copper sulfate, 7758-98-7, Copper(ii) sulfate, Copper sulphate, Cupric sulfate anhydrous, Copper(2+) sulfate
Molecular Formula
CuO4S
Molecular Weight
159.61  g/mol
InChI Key
ARUVKPQLZAKDPS-UHFFFAOYSA-L
FDA UNII
KUW2Q3U1VV

Copper Sulfate
A sulfate salt of copper. It is a potent emetic and is used as an antidote for poisoning by phosphorus. It also can be used to prevent the growth of algae.
1 2D Structure

Copper Sulfate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
copper;sulfate
2.1.2 InChI
InChI=1S/Cu.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2
2.1.3 InChI Key
ARUVKPQLZAKDPS-UHFFFAOYSA-L
2.1.4 Canonical SMILES
[O-]S(=O)(=O)[O-].[Cu+2]
2.2 Other Identifiers
2.2.1 UNII
KUW2Q3U1VV
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Blue Vitriol

2. Copper Sulfate

3. Sulfate, Copper

4. Sulfate, Cupric

5. Vitriol, Blue

2.3.2 Depositor-Supplied Synonyms

1. Copper Sulfate

2. 7758-98-7

3. Copper(ii) Sulfate

4. Copper Sulphate

5. Cupric Sulfate Anhydrous

6. Copper(2+) Sulfate

7. Copper(ii) Sulfate, Anhydrous

8. Copper Monosulfate

9. Cupricsulfate

10. Blue Stone

11. Copper(2+) Sulphate

12. Copper Ii Sulfate

13. Copper Sulfate (1:1)

14. Sulfuric Acid Copper(2+) Salt (1:1)

15. Copper;sulfate

16. Cuso4

17. Copper(ii) Sulphate

18. Coppersulfate

19. Copper(2+) Sulfate (1:1)

20. 10124-44-4

21. Copper Sulfate, Anhydrous

22. Copper Monosulphate

23. 18939-61-2

24. Sulfuric Acid, Copper(2+) Salt

25. Cupric Sulphate Anhydrous

26. Cupric Sulfate, Anhydrous

27. Cupric Sulphate, Anhydrous

28. Kuw2q3u1vv

29. Copper(ii) Sulfate Solution

30. 1332-14-5

31. Hylinec

32. Trinagle

33. Delcup

34. Sulfuric Acid, Coppersalt (8ci,9ci)

35. Monocopper Sulfate

36. Incracide 10a

37. Bcs Copper Fungicide

38. Blue Copper (van)

39. Bonide Root Destroyer

40. Copper Sulfate Powder

41. Kupfersulfat [german]

42. All Clear Root Destroyer

43. Snow Crystal Copper Sulfate

44. Sulfate De Cuivre [french]

45. Aqua Maid Permanent Algaecide

46. Ccris 3665

47. Hsdb 916

48. Granular Crystals Copper Sulfate

49. Copper (ii) Sulphate

50. Mac 570

51. Bluestone Copper Sulfate

52. Tobacco States Brand Copper Sulfate

53. Einecs 231-847-6

54. Phelps Triangle Brand Copper Sulfate

55. Unii-kuw2q3u1vv

56. Mfcd00010981

57. Nsc 57630

58. Sulfuric Acid, Copper Salt

59. Copper (ii) Sulfate Anhydrous

60. Sa-50 Brand Copper Sulfate Granular Crystals

61. Aquatronics Snail-a-cide Dri-pac Snail Powder

62. Copper(ii)sulphate

63. Copper(ii)-sulfate

64. Einecs 242-692-9

65. Copper (as Sulfate)

66. Copper Sulfate Chelate

67. Cuso4 Copper Sulphate

68. Copper (11) Sulfate

69. Copper( Cento) Sulfate

70. Sulfuric Acid, Copper(2+) Salt (1:?)

71. Cupric Sulfate,anhydrous

72. Bluestone, Cupric Sulfate

73. Copper(ii) Tetraoxosulfate

74. Cupric Sulfate [mi]

75. Copper Sulfate [inci]

76. Cupric Sulfate [hsdb]

77. Sulfuric Acid Copper(2+)salt

78. Copper Sulfate [who-dd]

79. Dtxsid6034479

80. Chebi:23414

81. Copper Sulphate (1:1)

82. Cupric Sulfate Anhydrous [ii]

83. Akos015902901

84. Copper(2+) Sulphate (1:1)

85. Db06778

86. Cupric Sulfate,anhydrous [vandf]

87. Bp-20356

88. Fishertab™ Ct-37 Kjeldahl Tablets

89. Fishertab™ Ct-50 Kjeldahl Tablets

90. Fishertab™ Tt-35 Kjeldahl Tablets

91. Fishertab™ Tt-43 Kjeldahl Tablets

92. Fishertab™ Tt-50 Kjeldahl Tablets

93. Fishertab™ Tt-57 Kjeldahl Tablets

94. Fishertab™ Ct-auto Kjeldahl Tablets

95. Ft-0624048

96. C18713

97. Copper Sulfate, Anhydrous [ep Impurity]

98. Cupric Sulfate Anhydrous [usp Monograph]

99. Cupric Sulphate, Copper Sulphate, Cupric Sulfate

100. A923422

101. Q107184

102. Sr-01000944582

103. Sr-01000944582-1

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 159.61 g/mol
Molecular Formula CuO4S
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count0
Exact Mass158.881327 g/mol
Monoisotopic Mass158.881327 g/mol
Topological Polar Surface Area88.6 Ų
Heavy Atom Count6
Formal Charge0
Complexity62.2
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Therapeutic Uses

Antidotes; Emetics; Fungicides, Industrial

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


/SRP: EXTERNAL/ ANTIDOTE FOR WHITE PHOSPHORUS POISONING.

SRI


/SRP: FORMER USE/ A 0.1% soln of copper sulfate has been used for gastric lavage in phosphorus poisoning; it must be removed promptly to avoid copper poisoning. Topical application of a 1% soln is of value for phosphorus burns of the skin.

Reynolds, J.E.F., Prasad, A.B. (eds.) Martindale-The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982., p. 931


EXPT USE: IN EXPT WITH RATS TO FIND SIMPLE EFFICIENT ANTIDOTE FOR PHOSPHORUS BURNS, USE OF 5% COPPER SULFATE WAS HIGHLY TOXIC. SOLN OF 5% SODIUM BICARBONATE WITH 1% HYDROXYETHYL-CELLULOSE, 3% COPPER SULFATE & LAURYL SULFATE NEUTRALIZES PROCESS OF BURNING PHOSPHORUS.

PMID:5047150 BEN-HUR N ET AL; BR J PLAST SURG 25 (3): 245-9 (1972)


For more Therapeutic Uses (Complete) data for COPPER(II) SULFATE (11 total), please visit the HSDB record page.


4.2 Drug Warning

... Its routine use as an emetic is not recommended, because of the potential toxicity of improperly prepared soln and the hazards attending the use of large, corrosive doses.

Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 748


Overdose may be poisonous (enteritis, hepatitis, nephritis).

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 136


MAY CAUSE DRAMATIC INCR IN MORTALITY OF TURKEYS GIVEN BLACKHEAD CONTROL DRUGS CONTAINING ARSENIC & EXPOSED TO BLACKHEAD.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 136


CUPRIC ... SULFATE /AS EMETIC/ OFTEN IS EFFECTIVE, BUT POTENTIAL HEMOLYTIC & RENAL TOXICITY IS TOO GREAT TO RECOMMEND USE.

American Medical Association, AMA Department of Drugs. AMA Drug Evaluations. 4th ed. Chicago: American Medical Association, 1980., p. 1436


4.3 Drug Indication

Elemental use in copper deficiency Copper and copper containing compounds are broadly used in medical practice. Metallic copper is used already for many years in dental fillings and in copper intrauterine devices (IUD) for reversible contraception. Ointments containing copper, which release copper ions that are absorbed by the skin in the management of cramps, disturbances of renal function, peripheral, venous hypostatic circulatory disturbances, rheumatic disease and swelling associated with trauma. There are also cosmetic facial creams containing copper as their main active ingredient.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Copper is an essential mineral that plays a key role in many physiological processes, including angiogenesis, skin generation and expression and stabilization of skin proteins. Copper is found naturally in many food sources including meats, vegetables, and grains. Copper has potent biocidal properties and is used to eliminate bacteria, viruses and parasites,. Copper is one of the nine essential minerals for humans, as it plays an imperative role in various physiological pathways in basically all human tissue, as well as in the health of the dermis and epidermis. In addition to the above, copper is essential in wound healing, as it promotes angiogenesis and skin extracellular matrix formation and stabilization.


5.2 MeSH Pharmacological Classification

Emetics

Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla. (See all compounds classified as Emetics.)


Antidotes

Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)


5.3 ATC Code

V - Various

V03 - All other therapeutic products

V03A - All other therapeutic products

V03AB - Antidotes

V03AB20 - Copper sulfate


5.4 Absorption, Distribution and Excretion

Absorption

Primarily absorbed in the small intestine. Based on studies with radioactive isotopes of copper, most copper is absorbed from the stomach and duodenum of the gastrointestinal tract. Maximum blood copper levels are observed within 1 to 3 hours following oral administration, and about 50 percent of ingested copper was absorbed. Copper absorption is proposed to occur by two mechanisms, one energy- dependent and the other enzymatic. Factors that can interfere with copper absorption include competition for binding sites with zinc, interactions with molybdenum and sulfates, chelation with phytates, and inhibition by ascorbic acid (vitamin C). Copper absorbed from the gastrointestinal tract is transported rapidly to blood serum and deposited in the liver bound to metallothionein. From 20 to 60% of the dietary copper is absorbed.


Route of Elimination

This drug is 80% eliminated via the liver in bile. Minimal excretion by the kidney. Metabolism studies show that persons with daily intakes of 2-5 mg of copper per day absorbed 0.6 to 1.6 mg (32%), excreted 0.5 to 1.3 mg in the bile, passed 0.1 to 0.3 mg directly into the bowel, and excreted 0.01 to 0.06 mg in the urine. As the data indicate, urinary excretion plays a negligible role in copper clearance, and the main route of excretion is in the bile. Other nonsignificant excretory routes include saliva, sweat, menstrual flow, and excretion into the intestine from the blood.


Volume of Distribution

The body of a 70 kg healthy individual contains approximately 110 mg of copper, 50% of which is found in the bones and muscles, 15% in the skin, 15% in the bone marrow, 10% in the hepatic system, and 8% in the brain. The distribution of copper is affected by sex, age, and the amount of copper in the diet. Brain and liver have the highest tissue levels (about one-third of the total body burden), with lesser concentrations found in the heart, spleen, kidneys, and blood. The iris and choroid of the eye have very high copper levels. Erythrocyte copper levels are generally stable, however, plasma levels fluctuate widely in association with the synthesis and release of ceruloplasmin. Plasma copper levels during gestation may be 2-3 times levels measured before pregnancy, due to the increased synthesis of ceruloplasmin.


Effect of hydrogen ion (H+) concentration, water hardness, suspended solids, fish age, size, and species, acclimatization to copper, and levels of copper in food on poisoning of fish by copper sulfate used as a herbicide in freshwater ponds is discussed. Copper levels in muscle, kidney, and organs of rainbow trout were approximately 0.8-1.1, 2.0-2.3, and 115-150 mg/kg fresh weight, respectively, after 12 months intermittent exposure to various copper sulfate containing formulations 0.6, 2.0, and 100 mg/kg, respectively, in controls ... .

Bohl M, Wagner H; Fisch Umwelt 10(Beitr Fischtoxikol - Parasitol): 121-7 (1981)


Male rats were orally administered for 2, 5, and 11 days with 0.5 mmol/kg of copper cmpd. ... In the case of cupric carbonate, copper was much more distributed in the tissues, especially in the liver, than for copper sulfate. The copper level increased progresively in mitochondria lysosomal fractions of the liver in proportion to the period of administration. In the 105,000 g supernatant fraction, copper was distributed in the metallothionein fraction rather than in the superoxide dismutase fraction. The administration of copper cmpd resulted in an increase in the zinc level in the liver, kidney and spleen, preferentially in the metallothionein fraction of the liver, but it seemed to have little effect on iron metabolism.

Fujita M et al; Eisei Kagaku 30 (2): 69-78 (1984)


5.5 Metabolism/Metabolites

Maximum blood copper levels were observed within 1 to 3 hours following oral administration, and about 50 percent of ingested copper was absorbed. Copper absorption is believed to occur by two mechanisms, one energy- dependent and the other enzymatic. Factors that can interfere with copper absorption include competition for binding sites with zinc, interactions with molybdenum and sulfates, chelation with phytates, and inhibition by ascorbic acid. Copper absorbed from the intestine is transported quickly into blood serum and deposited in the liver bound to metallothionein. It is released and incorporated into ceruloplasmin, a copper-specific transport protein. The remaining copper in the serum binds to albumin or amino acids or is contained in the erythrocytes. About 80 percent of the absorbed copper is bound to liver metallothionein; the remainder is included into cytochrome c oxidase or sequestered by lysosomes.


5.6 Biological Half-Life

The biological half-life of copper from the diet is 13-33 days with biliary excretion being the primary route of elimination.


5.7 Mechanism of Action

This drug is an essential trace element for the functioning of many metalloenzymes including ceruloplasmin, ferroxidase II, lysyl oxidase, monoamine oxidase, Zn-copper superoxide dismutase, tyrosinase, dopamine--hydroxylase, and cytochrome-c-oxidase. It is involved in erythropoiesis & leukopoiesis, bone mineralization, elastin and collagen cross-linking, oxidative phosphorylation, catecholamine metabolism, melanin formation & antioxidant protection of cells. Cupric sulfate may also have a role in iron turnover, ascorbic acid metabolism, phospholipid metabolism, myelin formation, glucose homeostasis, and cellular immune defense. After the metal passes through the basolateral membrane it is transported to the liver, attached to serum albumin. The liver is the critical organ for the homeostasis of copper. The copper is then prepared for excretion through the bile or incorporation into various proteins. The transport of copper to the peripheral tissues is accomplished through the plasma attached to serum albumin, ceruloplasmin or low-molecular-weight complexes. In the dermis, copper promotes dermal fibroblasts proliferation, upregulates collagen (types I, II, and V) and elastin fiber components (elastin, fibrillins) production by fibroblasts, through the induction of TGF-, promotes heat shock protein-47, important for collagen fibril formation, serves as a cofactor of LOX enzyme required for extracellular matrix protein cross-linking, stabilizes the skin ECM once formed, as increased crosslinking of collagen and elastin matrices occurs in a copper dose dependant manner, serves as a cofactor of superoxide dismutase, an antioxidant enzyme in the skin, essential for protection against free radicals, inhibits cellular oxidative effects such as membrane damage and lipid peroxidation, acts as a cofactor of tyrosinase, a melanin biosynthesis essential enzyme responsible for skin and hair pigmentation. In reference to its role as a biocide, copper is an essential nutrient for many organisms. It acts as a cofactor in respiration, and therefore copper is required for aerobic metabolism. Accumulation of copper ions or intracellular release of free copper ions from proteins lead to cell damage. Copper catalyzes reactions that result in the production of hydroxyl radicals through the Fenton and Haber-Weiss reactions. The highly reactive oxygen intermediates lead to lipid peroxidation and oxidation of proteins. Free copper ions oxidize sulfhydryl groups, such as cysteine, in proteins or the cellular redox buffer glutathione. In particular, copper ions inactivate proteins by damaging Fe-S clusters in cytoplasmic hydratases.


A significant drop in metabolic reserves was noted in cupric sulfate treated snails. Free amino acid levels dropped and the lactate level increased. The effects of copper treatment on rates of metabolite oxidation and ammonia production in the presence of exogenously added alpha-ketoglutarate were evaluated. A 92% drop in alpha-ketoglutarate dehydrogenase, a 33% drop in alanine aminotransferase, and a 78% rise in glucose 6-phosphatase were recorded. Molluscicidal activity of copper was due to a metabolic block in the tricarboxylic acid cycle at the alpha-ketoglutarate level.

PMID:3559915 Babu GR, Rao PV; J Environ Pathol Toxicol Oncol 7 (3): 29-34 (1987)


ACUTE IV INFUSION OF 300 MG COPPER SULFATE IN CONSCIOUS SHEEP CAUSED AN INCREASE FROM 10.3 TO 22.5 TORR IN MEAN PULMONARY ARTERY PRESSURE & PULMONARY ARTERY WEDGE PRESSURE FROM 3.5 TO 7.6 TORR, WHEREAS SYSTEMIC ARTERIAL PRESSURE INCREASED FROM 95 TO 102 TORR. CARDIAC OUTPUT DECREASED FROM 4.7 TO 3.3 L/MIN. PULMONARY VASCULAR RESISTANCE & SYSTEMIC VASCULAR RESISTANCE INCREASED TO 320 & 160% OF BASE LINE, RESPECTIVELY. THIS PULMONARY HYPERTENSION WAS PRODUCED BY STIMULATION OF THE ALPHA-ADRENERGIC NERVOUS SYSTEM.

PMID:6271712 AHMED T ET AL; J APPL PHYSIOL 51 (5): 1204-13 (1981)


Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Solubilizers

read-more
read-more

Granulation

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Taste Masking

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Cupric sulfate anhydrous Manufacturers

A Cupric sulfate anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cupric sulfate anhydrous, including repackagers and relabelers. The FDA regulates Cupric sulfate anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cupric sulfate anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cupric sulfate anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cupric sulfate anhydrous Suppliers

A Cupric sulfate anhydrous supplier is an individual or a company that provides Cupric sulfate anhydrous active pharmaceutical ingredient (API) or Cupric sulfate anhydrous finished formulations upon request. The Cupric sulfate anhydrous suppliers may include Cupric sulfate anhydrous API manufacturers, exporters, distributors and traders.

click here to find a list of Cupric sulfate anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cupric sulfate anhydrous USDMF

A Cupric sulfate anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of Cupric sulfate anhydrous active pharmaceutical ingredient (API) in detail. Different forms of Cupric sulfate anhydrous DMFs exist exist since differing nations have different regulations, such as Cupric sulfate anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Cupric sulfate anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. Cupric sulfate anhydrous USDMF includes data on Cupric sulfate anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cupric sulfate anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Cupric sulfate anhydrous suppliers with USDMF on PharmaCompass.

Cupric sulfate anhydrous NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cupric sulfate anhydrous as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Cupric sulfate anhydrous API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Cupric sulfate anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Cupric sulfate anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cupric sulfate anhydrous NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Cupric sulfate anhydrous suppliers with NDC on PharmaCompass.

Cupric sulfate anhydrous GMP

Cupric sulfate anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Cupric sulfate anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cupric sulfate anhydrous GMP manufacturer or Cupric sulfate anhydrous GMP API supplier for your needs.

Cupric sulfate anhydrous CoA

A Cupric sulfate anhydrous CoA (Certificate of Analysis) is a formal document that attests to Cupric sulfate anhydrous's compliance with Cupric sulfate anhydrous specifications and serves as a tool for batch-level quality control.

Cupric sulfate anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each Cupric sulfate anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Cupric sulfate anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (Cupric sulfate anhydrous EP), Cupric sulfate anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cupric sulfate anhydrous USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty